NCT06512779 Developing a Treatment Clustering System for Obstructive Sleep Apnea Using Polysomnographic Physiological Signals
| NCT ID | NCT06512779 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cheng-Kung University Hospital |
| Condition | Obstructive Sleep Apnea of Adult |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-07-30 |
| Primary Completion | 2026-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2024-07-30 with a primary completion date of 2026-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Obstructive sleep apnea syndrome (OSA) is marked by repeated upper airway obstructions during sleep, affecting approximately 14% of men and 5% of women aged 30-70 years. However, precise clinical prediction tools for selecting optimal treatment strategies are lacking. This study aims to develop an automated treatment clustering system using artificial intelligence to classify patients based on etiology into (i) anatomical factors, (ii) reduced muscle responsiveness, and (iii) other non-anatomical factors. This system will analyze physiological sleep assessments, such as electromyography (EMG) and pneumotachographs, from a retrospective polysomnography (PSG) database. Cross-validation will be conducted on new OSA patients undergoing various management strategies, including surgical intervention, CPAP therapy, and oropharyngeal training (delivered face-to-face or via telerehabilitation). This system aims to enhance clinicians' ability to predict treatment success rates and improve patient outcomes.
Eligibility Criteria
Inclusion Criteria: * OSA patients * Aged over 20 years Exclusion Criteria: * BMI≧ 32 * Central or mixed types of sleep apnea * A history of malignancy or infection of the head and neck region and laryngeal trauma * Craniofacial malformation * Stroke * Neuromuscular disease * Severe cardiovascular disease * Active psychiatric disease * Structural abnormalities over the upper respiratory airway * Performed any operation or treatment over the neck before * Pregnancy
Contact & Investigator
Ching-Hsia Hung, PhD
PRINCIPAL INVESTIGATOR
National Cheng Kung University
Frequently Asked Questions
Who can join the NCT06512779 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Obstructive Sleep Apnea of Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06512779 currently recruiting?
Yes, NCT06512779 is actively recruiting participants. Contact the research team at junhui.ong611@gmail.com for enrollment information.
Where is the NCT06512779 trial being conducted?
This trial is being conducted at Tainan, Taiwan.
Who is sponsoring the NCT06512779 clinical trial?
NCT06512779 is sponsored by National Cheng-Kung University Hospital. The principal investigator is Ching-Hsia Hung, PhD at National Cheng Kung University. The trial plans to enroll 150 participants.